日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A CD138+ tumor-associated macrophage/Siglec-F+ neutrophil feed-forward loop promotes immune evasion in pancreatic cancer

CD138+肿瘤相关巨噬细胞/Siglec-F+中性粒细胞前馈环路促进胰腺癌的免疫逃逸

Wang, Chao; Zhang, Qi; Huang, Jinyan; Lin, Fangyu; Zhao, Danyang; Mu, Youling; Tong, Junshuo; Li, Jinping; Liang, Yingjiqiong; Zeng, Tao; Shi, Fukang; Shen, Hang; Lu, Tingting; Liang, Tingbo

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome

优化多发性骨髓瘤的精准预后:CD138+浆细胞中miR-221/222簇的缺失会导致短期疾病进展和更差的治疗效果

Soureas, Konstantinos; Malandrakis, Panagiotis; Papadimitriou, Maria-Alexandra; Minopoulos, Christos; Ntanasis-Stathopoulos, Ioannis; Liacos, Christine-Ivy; Gavriatopoulou, Maria; Kastritis, Efstathios; Dimopoulos, Meletios-Athanasios; Scorilas, Andreas; Avgeris, Margaritis; Terpos, Evangelos

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

本研究对接受PVX-410疫苗(靶向XBP1/CD138/CS1抗原)和西他诺司他(一种组蛋白去乙酰化酶抑制剂,HDACi)联合或不联合来那度胺治疗的冒烟型多发性骨髓瘤患者进行了Ib期临床试验,并分析了接受西他诺司他治疗的冒烟型多发性骨髓瘤患者的免疫特征。

Cirstea, Diana; Shome, Rajib; Samur, Mehmet; Talluri, Srikanth; Connolly, Joseph J; Wright, Alexandra Jean; Duvallet, Emilie; Joyce, Amanda N R; Lively, Kathleen; Basinsky, Gina; Yee, Andrew J; Chase, Cristiana Costa; Malek, Ehsan; Niesvizky, Ruben; Richardson, Paul G; Raje, Noopur S

Role of CD138(+) Plasma Cells and Natural Killer Cells in Couple Infertility: A Review

CD138(+)浆细胞和自然杀伤细胞在夫妇不孕症中的作用:综述

Messina, Alessandro; Libretti, Alessandro; Giovannini, Ilaria; Leo, Livio; Remorgida, Valentino; Masturzo, Bianca; Tinelli, Raffaele

Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic Regimens

对骨髓CD138+细胞进行蛋白质组学分析,以鉴定与多发性骨髓瘤患者对常用治疗方案的反应相关的蛋白质

Paradeisi, Foteini; Tserga, Aggeliki; Lygirou, Vasiliki; Makridakis, Manousos; Stroggilos, Rafael; Georgiou, Grigoris; Spyrou, George M; Kostopoulos, Ioannis V; Liacos, Christine-Ivy; Termentzi, Aikaterini; Dimopoulos, Meletios A; Tsitsilonis, Ourania; Vlahou, Antonia; Kastritis, Efstathios; Zoidakis, Jerome

Decreased expression of Syndecan- 1 (CD138) in the endometrium of adenomyosis patients suggests a potential pathogenetic role

子宫腺肌症患者子宫内膜中 Syndecan-1 (CD138) 表达降低提示其可能具有致病作用。

Shaalan, Walid; Ibrahim, Mohamed Gamal; Plasger, Ariana; Hassan, Nourhan; Kiesel, Ludwig; Schüring, Andreas N; Götte, Martin

Diagnostic value of CD138 and GATA3 in benign prostatic hyperplasia and prostate cancer

CD138 和 GATA3 在良性前列腺增生和前列腺癌诊断中的价值

Hu, Yang; Dan, Luo; Shikun, Yang; Junbo, Lian; Shuangjie, Huo; Liru, Dong

Profilin 1 induces drug resistance by downregulating CD138 expression via autophagy in multiple myeloma

Profilin 1 通过自噬下调 CD138 表达诱导多发性骨髓瘤耐药性

Wang, Ya; Dai, ZiYu; Xiao, Shengying; Zeng, Furen; Lu, YiChen

Initial Circulating CD138 Predicts End-Stage Kidney Disease in Patients with Microscopic Polyangiitis

初始循环CD138水平可预测显微镜下多血管炎患者的终末期肾病

Pyo, Jung Yoon; Park, Yong-Beom; Lee, Sang-Won

Heterohybridomas producing human immunoglobulin light chains using CD138-selected bone marrow cells

利用CD138选择的骨髓细胞产生人免疫球蛋白轻链的异质杂交瘤

Zhou, P; Ma, X; Scalia, S; Toskic, D; Wu, X; Fogaren, T; Lyons, Nancy Coady; Del Pozo-Yauner, Luis; Comenzo, R L